Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Sitagliptin Phosphate in Uveal Melanoma: NCT07634380 Clinical Landscape Report 2026
16 September 2026
NCT07634380 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tumor infiltrating lymphocytes(NCI) in Melanoma, Cutaneous Malignant: NCT07628894 Clinical Landscape Report 2026
16 September 2026
NCT07628894 clinical landscape for Melanoma, Cutaneous Malignant: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tocilizumab in Lupus Nephritis: NCT07629583 Clinical Landscape Report 2026
16 September 2026
NCT07629583 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Axatilimab-csfr in High grade B-cell lymphoma: NCT07638982 Clinical Landscape Report 2026
16 September 2026
NCT07638982 clinical landscape for High grade B-cell lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07635485 Clinical Landscape Report 2026
16 September 2026
NCT07635485 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells) (Adjuvant)(Yikang ) in Retinoblastoma: NCT07633756 Clinical Landscape Report 2026
16 September 2026
NCT07633756 clinical landscape for Retinoblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Temozolomide in Glioblastoma Multiforme: NCT07635173 Clinical Landscape Report 2026
16 September 2026
NCT07635173 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Probiotic(Mendes) in Uterine Cervical Cancer: CTRI/2026/06/112392 Clinical Landscape Report 2026
16 September 2026
CTRI/2026/06/112392 clinical landscape for Uterine Cervical Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
The-0504 in Small Cell Lung Cancer: NCT07646106 Clinical Landscape Report 2026
16 September 2026
NCT07646106 clinical landscape for Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sparfosic acid in Dermatitis, Atopic: CTRI/2026/06/112360 Clinical Landscape Report 2026
16 September 2026
CTRI/2026/06/112360 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tapinarof in Plaque psoriasis: NCT07635043 Clinical Landscape Report 2026
16 September 2026
NCT07635043 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tofacitinib Citrate in Psoriasis vulgaris: CTRI/2026/06/112460 Clinical Landscape Report 2026
16 September 2026
CTRI/2026/06/112460 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.